Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 366 Thousand CAD | 7.65% |
| 2022 | 340 Thousand CAD | 16.04% |
| 2021 | 293 Thousand CAD | -15.8% |
| 2020 | 348 Thousand CAD | 26.09% |
| 2019 | 276 Thousand CAD | 40.1% |
| 2018 | 197 Thousand CAD | 3.14% |
| 2017 | 191 Thousand CAD | -21.72% |
| 2016 | 244 Thousand CAD | 0.41% |
| 2015 | 243 Thousand CAD | 46.39% |
| 2014 | 166 Thousand CAD | -47.3% |
| 2013 | 315 Thousand CAD | 13.72% |
| 2012 | 277 Thousand CAD | -6.1% |
| 2011 | 295 Thousand CAD | 41.15% |
| 2010 | 209 Thousand CAD | 69.92% |
| 2009 | 123 Thousand CAD | -39.41% |
| 2008 | 203 Thousand CAD | -18.47% |
| 2007 | 249 Thousand CAD | -1.58% |
| 2006 | 253 Thousand CAD | -81.27% |
| 2005 | 1.35 Million CAD | 10.11% |
| 2004 | 1.22 Million CAD | -33.93% |
| 2003 | 1.85 Million CAD | 20.9% |
| 2002 | 1.53 Million CAD | -9.33% |
| 2001 | 1.69 Million CAD | 30.31% |
| 2000 | 1.3 Million CAD | -13.33% |
| 1999 | 1.5 Million CAD | 50.0% |
| 1998 | 1 Million CAD | -9.09% |
| 1997 | 1.1 Million CAD | 120.0% |
| 1996 | 500 Thousand CAD | 400.0% |
| 1995 | 100 Thousand CAD | 0.0% |
| 1994 | - CAD | 0.0% |
| 1993 | - CAD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 319 Thousand CAD | -12.84% |
| 2024 Q2 | 272 Thousand CAD | -14.73% |
| 2023 Q3 | 304 Thousand CAD | 5.56% |
| 2023 Q2 | 288 Thousand CAD | -17.48% |
| 2023 Q4 | 366 Thousand CAD | 20.39% |
| 2023 FY | 366 Thousand CAD | 7.65% |
| 2023 Q1 | 349 Thousand CAD | 2.65% |
| 2022 Q4 | 340 Thousand CAD | -48.48% |
| 2022 Q1 | 519 Thousand CAD | 77.13% |
| 2022 Q2 | 463 Thousand CAD | -10.79% |
| 2022 Q3 | 660 Thousand CAD | 42.55% |
| 2022 FY | 340 Thousand CAD | 16.04% |
| 2021 Q4 | 293 Thousand CAD | -26.57% |
| 2021 Q1 | 367 Thousand CAD | 5.46% |
| 2021 Q2 | 296 Thousand CAD | -19.35% |
| 2021 Q3 | 399 Thousand CAD | 34.8% |
| 2021 FY | 293 Thousand CAD | -15.8% |
| 2020 Q2 | 348 Thousand CAD | 32.82% |
| 2020 Q3 | 343 Thousand CAD | -1.44% |
| 2020 FY | 348 Thousand CAD | 26.09% |
| 2020 Q1 | 262 Thousand CAD | -5.07% |
| 2020 Q4 | 348 Thousand CAD | 1.46% |
| 2019 Q1 | 193 Thousand CAD | -2.03% |
| 2019 Q3 | 264 Thousand CAD | -10.51% |
| 2019 Q4 | 276 Thousand CAD | 4.55% |
| 2019 FY | 276 Thousand CAD | 40.1% |
| 2019 Q2 | 295 Thousand CAD | 52.85% |
| 2018 FY | 197 Thousand CAD | 3.14% |
| 2018 Q2 | 232 Thousand CAD | -22.15% |
| 2018 Q3 | 289 Thousand CAD | 24.57% |
| 2018 Q1 | 298 Thousand CAD | 56.02% |
| 2018 Q4 | 197 Thousand CAD | -31.83% |
| 2017 Q4 | 191 Thousand CAD | -13.96% |
| 2017 FY | 191 Thousand CAD | -21.72% |
| 2017 Q3 | 222 Thousand CAD | -19.57% |
| 2017 Q2 | 276 Thousand CAD | 6.56% |
| 2017 Q1 | 259 Thousand CAD | 6.15% |
| 2016 FY | 244 Thousand CAD | 0.41% |
| 2016 Q2 | 436 Thousand CAD | 34.15% |
| 2016 Q4 | 244 Thousand CAD | -36.46% |
| 2016 Q3 | 384 Thousand CAD | -11.93% |
| 2016 Q1 | 325 Thousand CAD | 33.74% |
| 2015 Q4 | 243 Thousand CAD | -4.71% |
| 2015 FY | 243 Thousand CAD | 46.39% |
| 2015 Q3 | 255 Thousand CAD | -4.49% |
| 2015 Q2 | 267 Thousand CAD | 22.48% |
| 2015 Q1 | 218 Thousand CAD | 31.33% |
| 2014 Q3 | 179 Thousand CAD | -1.65% |
| 2014 Q4 | 166 Thousand CAD | -7.26% |
| 2014 FY | 166 Thousand CAD | -47.3% |
| 2014 Q1 | 189 Thousand CAD | -40.0% |
| 2014 Q2 | 182 Thousand CAD | -3.7% |
| 2013 FY | 315 Thousand CAD | 13.72% |
| 2013 Q3 | 357 Thousand CAD | -14.59% |
| 2013 Q4 | 315 Thousand CAD | -11.76% |
| 2013 Q2 | 418 Thousand CAD | 0.0% |
| 2013 Q1 | 418 Thousand CAD | 50.9% |
| 2012 FY | 277 Thousand CAD | -6.1% |
| 2012 Q4 | 277 Thousand CAD | 30.05% |
| 2012 Q2 | 245 Thousand CAD | -5.41% |
| 2012 Q3 | 213 Thousand CAD | -13.06% |
| 2012 Q1 | 259 Thousand CAD | -12.2% |
| 2011 Q3 | 240 Thousand CAD | 1.69% |
| 2011 Q4 | 295 Thousand CAD | 22.92% |
| 2011 Q1 | 176 Thousand CAD | -15.79% |
| 2011 FY | 295 Thousand CAD | 41.15% |
| 2011 Q2 | 236 Thousand CAD | 34.09% |
| 2010 Q1 | 242 Thousand CAD | 96.75% |
| 2010 FY | 209 Thousand CAD | 69.92% |
| 2010 Q4 | 209 Thousand CAD | -16.73% |
| 2010 Q2 | 340 Thousand CAD | 40.5% |
| 2010 Q3 | 251 Thousand CAD | -26.18% |
| 2009 Q4 | 123 Thousand CAD | -40.58% |
| 2009 Q3 | 207 Thousand CAD | 10.7% |
| 2009 FY | 123 Thousand CAD | -39.41% |
| 2009 Q2 | 187 Thousand CAD | -8.33% |
| 2009 Q1 | 204 Thousand CAD | 0.49% |
| 2008 Q3 | 193 Thousand CAD | -9.81% |
| 2008 Q4 | 203 Thousand CAD | 5.18% |
| 2008 FY | 203 Thousand CAD | -18.47% |
| 2008 Q2 | 214 Thousand CAD | -12.3% |
| 2008 Q1 | 244 Thousand CAD | -2.01% |
| 2007 Q2 | 353 Thousand CAD | 2.32% |
| 2007 Q4 | 249 Thousand CAD | -29.46% |
| 2007 Q1 | 345 Thousand CAD | 0.0% |
| 2007 FY | 249 Thousand CAD | -1.58% |
| 2007 Q3 | 353 Thousand CAD | 0.0% |
| 2006 FY | 253 Thousand CAD | -81.27% |
| 2006 Q3 | 126 Thousand CAD | 20.0% |
| 2006 Q2 | 105 Thousand CAD | 144.19% |
| 2006 Q1 | 43 Thousand CAD | -97.29% |
| 2005 FY | 1.35 Million CAD | 10.11% |
| 2005 Q4 | 1.58 Million CAD | 8.87% |
| 2005 Q1 | 1.35 Million CAD | -4.18% |
| 2005 Q2 | 1.41 Million CAD | 4.44% |
| 2005 Q3 | 1.45 Million CAD | 3.12% |
| 2004 Q3 | 1.48 Million CAD | -2.5% |
| 2004 Q2 | 1.52 Million CAD | 24.12% |
| 2004 Q4 | 1.41 Million CAD | -5.05% |
| 2004 FY | 1.22 Million CAD | -33.93% |
| 2004 Q1 | 1.22 Million CAD | -19.7% |
| 2003 Q1 | 1.85 Million CAD | -20.37% |
| 2003 FY | 1.85 Million CAD | 20.9% |
| 2003 Q4 | 1.52 Million CAD | 8.83% |
| 2003 Q3 | 1.4 Million CAD | 3.16% |
| 2003 Q2 | 1.36 Million CAD | -26.71% |
| 2002 Q4 | 2.33 Million CAD | 24.84% |
| 2002 Q2 | 1.25 Million CAD | -18.29% |
| 2002 Q1 | 1.53 Million CAD | 20.66% |
| 2002 FY | 1.53 Million CAD | -9.33% |
| 2002 Q3 | 1.86 Million CAD | 48.84% |
| 2001 Q2 | 1.53 Million CAD | -9.62% |
| 2001 Q1 | 1.69 Million CAD | -0.82% |
| 2001 Q3 | 1.36 Million CAD | -11.1% |
| 2001 Q4 | 1.27 Million CAD | -6.47% |
| 2001 FY | 1.69 Million CAD | 30.31% |
| 2000 Q3 | 1.68 Million CAD | 0.0% |
| 2000 FY | 1.3 Million CAD | -13.33% |
| 2000 Q2 | - CAD | -100.0% |
| 2000 Q4 | 1.7 Million CAD | 1.36% |
| 2000 Q1 | 1.3 Million CAD | 0.0% |
| 1999 Q1 | 1.5 Million CAD | 0.0% |
| 1999 Q4 | - CAD | 0.0% |
| 1999 FY | 1.5 Million CAD | 50.0% |
| 1999 Q3 | - CAD | 0.0% |
| 1999 Q2 | - CAD | -100.0% |
| 1998 Q3 | - CAD | -100.0% |
| 1998 Q2 | 1.1 Million CAD | 10.0% |
| 1998 FY | 1 Million CAD | -9.09% |
| 1998 Q4 | - CAD | 0.0% |
| 1998 Q1 | 1 Million CAD | 0.0% |
| 1997 Q3 | - CAD | 0.0% |
| 1997 Q4 | - CAD | 0.0% |
| 1997 Q1 | 1.1 Million CAD | 0.0% |
| 1997 FY | 1.1 Million CAD | 120.0% |
| 1997 Q2 | - CAD | -100.0% |
| 1996 Q2 | - CAD | -100.0% |
| 1996 Q3 | - CAD | 0.0% |
| 1996 FY | 500 Thousand CAD | 400.0% |
| 1996 Q1 | 500 Thousand CAD | 0.0% |
| 1996 Q4 | - CAD | 0.0% |
| 1995 Q2 | - CAD | -100.0% |
| 1995 Q4 | - CAD | 0.0% |
| 1995 FY | 100 Thousand CAD | 0.0% |
| 1995 Q1 | 100 Thousand CAD | 0.0% |
| 1995 Q3 | - CAD | 0.0% |
| 1994 Q2 | - CAD | 0.0% |
| 1994 Q1 | - CAD | 0.0% |
| 1994 FY | - CAD | 0.0% |
| 1994 Q4 | - CAD | 0.0% |
| 1994 Q3 | - CAD | 0.0% |
| 1993 FY | - CAD | 0.0% |
| 1993 Q1 | - CAD | 0.0% |
| 1992 Q4 | - CAD | 0.0% |
| 1992 Q2 | - CAD | 0.0% |
| 1992 Q3 | - CAD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| American Bio Medica Corporation | 379 Thousand USD | 3.43% |
| Arrayit Corporation | 464.19 Thousand USD | 21.153% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 757 Thousand USD | 51.651% |
| Bioqual, Inc. | - USD | -Infinity% |
| CardioGenics Holdings Inc | -2385.00 USD | 15445.912% |
| DermTech, Inc. | 1 Million USD | 63.546% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 3.29 Million USD | 88.906% |
| HTG Molecular Diagnostics, Inc. | 909.32 Thousand USD | 59.75% |
| iMD Companies, Inc. | 38.31 Thousand USD | -855.215% |
| IDenta Corp. | 442.28 Thousand USD | 17.247% |
| Interpace Biosciences, Inc. | 1.22 Million USD | 70.171% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 163.13 Thousand USD | -124.354% |
| Lumos Diagnostics Holdings Limited | 784 Thousand USD | 53.316% |
| Many Bright Ideas Technologies Inc. | -375.00 USD | 97700.0% |
| Medical Imaging Corp. | - USD | -Infinity% |
| NovelStem International Corp. | - USD | -Infinity% |
| Optigenex Inc. | 468.77 Thousand USD | 21.924% |
| PharmChem, Inc. | 391.93 Thousand USD | 6.618% |
| Proteome Sciences plc | 1.06 Million USD | 65.65% |
| Response Genetics, Inc | 133 Thousand USD | -175.188% |
| Rennova Health, Inc. | 242.64 Thousand USD | -50.838% |
| RushNet, Inc. | - USD | -Infinity% |
| ScreenPro Security Inc. | 73.89 Thousand USD | -395.284% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 95.62 Thousand USD | -282.761% |
| Todos Medical Ltd. | 1.02 Million USD | 64.153% |